Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atypical chronic myeloid leukemias

D Oscier1

  • 1Royal Bournemouth Hospital, Department of Haematology, UK.

Pathologie-Biologie
|December 24, 1997
PubMed
Summary

A comprehensive classification of chronic myeloid leukemias (CML) requires understanding their causes and progression. Ongoing research in cellular and molecular biology aims to clarify the relationships between different CML subtypes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Leukemia·2016
Same author

Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.

Leukemia & lymphoma·2016
Same author

The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1.

Leukemia·2015
Same author

KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.

Leukemia·2014
Same author

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Leukemia·2014
Same author

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.

Leukemia·2013

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Chronic myeloid leukemias (CML) lack a definitive classification due to incomplete understanding of their etiology and pathogenesis.
  • Current diagnostic criteria for most CML subtypes rely heavily on clinical and morphological assessments.
  • The pathogenesis of chronic granulocytic leukemia (CGL) is well-understood, unlike other CML forms.

Purpose of the Study:

  • To highlight the need for an ideal classification system for chronic myeloid leukemias.
  • To emphasize the current diagnostic challenges and the reliance on clinical and morphological criteria.
  • To underscore the importance of integrating advances in cellular and molecular biology for resolving classification debates.

Main Methods:

  • Review of existing literature on CML classification, etiology, pathogenesis, and clinical features.
  • Analysis of diagnostic criteria based on clinical and morphological assessments.
  • Discussion of the role of cellular and molecular biology in advancing CML understanding.

Main Results:

  • The pathogenesis of only chronic granulocytic leukemia (CGL) is well-understood.
  • Diagnosis of other CML disorders largely depends on clinical and morphological criteria.
  • Cases may defy classification or meet criteria for multiple disorders.

Conclusions:

  • An ideal CML classification necessitates a deep understanding of etiology, pathogenesis, clinical/laboratory features, and natural history.
  • Advances in cellular and molecular biology are crucial for resolving diagnostic ambiguities and inter-relationships between CML subtypes like CMML, aCML, and Philadelphia-negative CGL.
  • Continued clinical and morphological observation alongside molecular research is essential for accurate CML classification.

Related Experiment Videos